Evaluation of the effect of mavacamten on left ventricular function in obstructive hypertrophic cardiomyopathy using myocardial work
Clinical Physiology and Functional Imaging · 2026-07 · 46 (4)
DOI: 10.1111/cpf.70084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Physiology and Functional Imaging, online erschienen am 27.07.2026. Verfasst von Linlin Wan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Echocardiography, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Ventricular Function, Left, Energy Metabolism, Ventricular Outflow Obstruction, Left. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China-Youth Foundation.
Abstract (Originalsprache)
Objective
To evaluate the effect of 12‐week Mavacamten on left ventricular function in obstructive hypertrophic cardiomyopathy (oHCM) using myocardial work analysis, and explore its role in myocardial energy metabolism.
Methods
Thirty‐five oHCM patients and 35 matched healthy controls were enroled. Patients received Mavacamten for 12 weeks. At baseline and post‐treatment, we measured LVOT gradient, LVEF, GLS, myocardial work parameters [GWI, GCW, GWW, GWE], mitral regurgitation severity, and SAM.
Results
Myocardial work parameters showed good reproducibility (ICCs > 0.75). After 12 weeks, resting and provoked LVOT gradients significantly decreased (both p < 0.001). Proportions of moderate/severe mitral regurgitation and SAM reduced. GWI, GCW, and GWW decreased ( p < 0.001), while GWE increased ( p < 0.001). NT‐proBNP decreased and NYHA functional class improved ( p < 0.001). LVEF, GLS, and left atrial diameter showed no significant changes. Compared with controls, baseline oHCM patients had lower GWI, GCW, GWE and higher GWW (all p < 0.001). After treatment, GWE remained lower than controls ( p < 0.001), and GWW remained higher ( p < 0.001).
Conclusion
Twelve‐week Mavacamten reduces LVOT obstruction in oHCM, accompanied by decreased GWI and increased GWE, while preserving systolic function and improving symptoms. Myocardial work parameters may serve as novel non‐invasive references for treatment evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Echocardiography, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
- Department of Echocardiography, Nanjing First Hospital, Nanjing University of Chinese Medicine, Nanjing, China.
- Department of Echocardiography, Nanjing First Hospital, China Pharmaceutical University, Nanjing, China.
ORCID-Profile: Linlin Wan, Ziwei Huang
Förderung
- National Natural Science Foundation of China-Youth Foundation
Zitieren
APA
Wan, L., Chen, X., Huang, Z., Ren, J., Lu, W., & Ran, H. (2026). Evaluation of the effect of mavacamten on left ventricular function in obstructive hypertrophic cardiomyopathy using myocardial work. Clinical Physiology and Functional Imaging, 46(4). https://doi.org/10.1111/cpf.70084
Vancouver
Wan L, Chen X, Huang Z, Ren J, Lu W, Ran H. Evaluation of the effect of mavacamten on left ventricular function in obstructive hypertrophic cardiomyopathy using myocardial work. Clinical Physiology and Functional Imaging. 2026;46(4). doi:10.1111/cpf.70084
BibTeX
@article{Wan2026,
author = {Wan, Linlin and Chen, Xixi and Huang, Ziwei and Ren, Junyi and Lu, WenJuan and Ran, Hong},
title = {Evaluation of the effect of mavacamten on left ventricular function in obstructive hypertrophic cardiomyopathy using myocardial work},
journal = {Clinical Physiology and Functional Imaging},
year = {2026},
volume = {46},
number = {4},
doi = {10.1111/cpf.70084}
}
EUVIMED